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Abstract
We investigated the toxicity of hemoglobin/myoglobin on endothelial cells under oxidative stress conditions that include
cellular hypoxia and reduced antioxidant capacity. Bovine aorta endothelial cells (BAECs), grown on microcarrier beads,
were subjected to cycles of hypoxia and reoxygenation in a small volume of medium, and endothelial cell monolayers were
depleted of their intracellular glutathione (GSH) by treatment with buthionine sulfoximine. Incubation of diaspirin cross-
linked hemoglobin (DBBF-Hb) or horse skeletal myoglobin (Mb) with BAECs subjected to 3 h of hypoxia caused transient
oxidation of the hemoproteins to the ferryl form (Fe4). Formation of the ferryl intermediate was decreased in a
concentration-dependent manner by the addition of L-arginine, a substrate of NO synthase, after 3 h of hypoxia. Optimal
inhibition of ferryl formation, possibly due to the antioxidant action of NO, was achieved with 900 WM L-arginine. Addition
of hydrogen peroxide to GSH-depleted cells in the presence of DBBF-Hb or Mb significantly decreased cell viability. Ferryl
Mb, but not ferryl DBBF-Hb, was observed in samples analyzed at the end of treatment, which may explain the greater
toxicity observed with Mb as opposed to DBBF-Hb. This model may be utilized to identify causative agent(s) associated with
hemoprotein cytotoxicity and in designing strategies to suppress or control heme-mediated injury under physiologically
relevant conditions. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Vascular endothelial cells play a pivotal role in the
in£ammatory process by coordinating the recruit-
ment of in£ammatory cells to sites of injury through
the production of a number of important physiolog-
ical mediators [1]. Interactions of heme proteins with
the vascular system have been suggested to play a
key role in the pathophysiology of oxidant-induced
vascular injury, including cerebral hemorrhage, blast
pressure injury, crush injury, myocardial ischemia/re-
perfusion, and rhabdomyolysis [2^6]. These condi-
tions are generally characterized by the release of
hemoglobin or myoglobin as a result of red blood
cell hemolysis or muscle destruction, respectively. In
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addition, a variety of oxygen-carrying blood substi-
tutes are being developed, based on modi¢ed forms
of hemoglobins, that have been shown to interfere
with normal endothelial responses [7,8].
Mechanistic analysis of the redox reactions of a
number of chemically modi¢ed hemoglobins and re-
combinant myoglobins with reactive nitrogen and
oxygen species both in vitro and in cell culture has
revealed the formation of the ferryl heme iron (Fe4),
a higher oxidation state and the most reactive oxida-
tive intermediate of hemoglobin or myoglobin [8^14].
One concern relevant to the use of hemoglobin as a
blood substitute is that in vivo production of ferryl-
hemoglobin may occur under conditions of ischemia
and reperfusion in patients with a diminished ability
to control oxidative reactions of hemoglobin.
Myoglobin in the extracellular milieu, like hemo-
globin, undergoes autoxidation to the ferric form
(Fe3), a catalytically competent species that can
promote lipid peroxidation through an Fe3/Fe4 re-
dox cycle driven by hydrogen peroxide (H2O2) or
lipid hydroperoxide. The reaction of hemoglobin/my-
oglobin with H2O2 proceeds via the formation of the
highly reactive ferryl intermediate (Fe4), which can
then auto-reduce to the ferric (Fe3) form [10,11].
Although the exact mechanism is not well under-
stood, the electron donor for this autoreduction
may involve a tyrosyl residue [11]. These reactions,
even at stoichiometric levels, occur much more
quickly than simple autoxidation and represent po-
tentially signi¢cant pathways for hemoglobin/myo-
globin degradation and cytotoxicity. The pseudoper-
oxidase catalytic cycle of Fe3/Fe4, as hemoglobin
consumes peroxide, has been reported to occur in the
red blood cell as part of its antioxidant defense
mechanisms [13]. The physiological signi¢cance of
these reactions is underscored by the fact that
H2O2 is produced by a variety of circulating cell
types primed and/or activated by physical trauma
(e.g. platelets, neutrophils and macrophages). More-
over, the globin radical of the ferryl hemoglobin has
recently been detected by electron paramagnetic res-
onance spectroscopy (EPR) in human and animal
whole blood [15]. The redox Fe3/Fe4 cycle of my-
oglobin has recently been shown to be the principal
causative factor in rhabdomyolysis-induced renal
failure [6]. Despite its transient nature and ultimate
self-destruction the Fe4 heme can peroxidize lipids,
degrade carbohydrates, and modify proteins [12].
The oxidative power of the Fe4 heme protein lies
within its high redox potential (E0 = +1.4 V for Fe4
compared to 0.15 V and +0.04 V for Fe2 and Fe3,
respectively). Thus, the transformation of hemoglo-
bin/myoglobin to a redox active compound, as it
consumes H2O2, may explain some of the unique
toxicological e¡ects observed with hemoproteins.
Since its recognition as endothelium-derived relax-
ing factor, nitric oxide (NO) has been implicated in
numerous physiological and non-physiological pro-
cesses [1]. In addition to its broad regulatory func-
tions, NO serves in mammalian physiology as an
important antioxidant [3,16,17]. The two major anti-
oxidant mechanisms of NO are: (1) direct oxygen
radical scavenging capable of maintaining a balance
between reactive oxygen and nitrogen intermediates
at the site of tissue injury and (2) direct redox inter-
action with hemoproteins that suppresses the forma-
tion of potent cytotoxic oxidants, i.e. heme-associ-
ated oxyferryl radicals.
In this work, we describe the development of an
endothelial cell culture model that may be useful in
mimicking some of the biological oxidative responses
of the vascular system to hemoproteins. We studied
two types of hemoproteins, myoglobin and diaspirin
cross-linked human hemoglobin (DBBF-Hb), a can-
didate blood substitute that has been extensively
studied in vivo and in vitro, based on their di¡erent
susceptibility to oxidative modi¢cation (for a review
see [18]). Oxidative stress was induced by subjecting
endothelial cells, grown on microcarrier beads, to
volume restriction and hypoxia, and by depleting
cells, grown in monolayers, of their endogenous glu-
tathione in the presence and absence of hemopro-
teins.
2. Materials and methods
2.1. Hemoglobin and myoglobin solutions
DBBF-Hb was a kind gift from the Walter Reed
Army Institute of Research, Washington, DC. The
structural modi¢cation, resulting from the reaction
of human deoxyhemoglobin with bis(3,5-dibromosa-
licyl)fumarate, involves the cross-linking of the two
K chains of hemoglobin between the lysine residues
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at position 99. Steady-state oxygen binding charac-
teristics of DBBF-Hb are close to those of human
blood with a P50 (the PO2 where half the heme sites
contain oxygen) of 28 Torr. Other functional and
oxidative properties of this protein have previously
been published [10]. Horse skeletal myoglobin was
purchased from Sigma (St. Louis, MO). Myoglobin
was reduced back to its ferrous form by treatment
with sodium dithionite followed by puri¢cation over
a Sephadex G-25 column.
2.2. Sources of BAECs
Bovine aortic endothelial cells (BAECs) (#BW-
6002, Clonetics, San Diego, CA) were grown in
EGM supplemented with 10 ng/ml human recombi-
nant epidermal growth factor, 1 Wg/ml hydrocorti-
sone, 10 Wg/ml bovine brain extract, 5% fetal bovine
serum, 50 Wg/ml gentamicin, and 50 ng/ml amphoter-
icin B. Cells were cultured in Petri dishes (100 mm
diameter) and kept in a 37‡C humidi¢ed incubator
with 95% air/5% CO2. Experimental data were ob-
tained from BAECs in their second to eighth pas-
sage.
2.3. Endothelial cell model of
hypoxia/reoxygenation
BAECs were grown to con£uence on suspended
collagen-coated Cytodex 3 microcarrier beads (Sig-
ma, St. Louis, MO). Brie£y, hydrated Cytodex
3 beads (0.08 g) were added to BAECs (106 cells)
in a 100-mm culture dish, and cells were allowed to
grow to con£uence. To initiate hypoxia, 2U105 cells
on beads were pipetted into a conical centrifuge tube
and allowed to settle, and the excess medium was
transferred to a separate £ask (hypoxia-volume re-
striction). The headspace of the centrifuge tube was
£ushed with nitrogen containing 5% CO2 and incu-
bated at 37‡C for the speci¢ed period of time. To
initiate reoxygenation, the cells and beads were re-
suspended in the original volume of warm, normoxic
medium and aliquoted into a 12-well tissue culture
plate. The model has been previously characterized
with regard to endogenous depletion of oxygen, in-
tra- and extracellular pH changes, calcium £uxes,
ATP depletion, lactate release, and lipid oxidation
and metabolism [9,19].
2.4. Endothelial cells growth in L-arginine-free
medium
Endothelial cells, grown on microcarrier beads,
were washed with RPMI (Gibco, New York) argi-
nine-free medium containing 10% fetal bovine serum
(Gibco), penicillin (5000 U/ml)^streptomycin (5 mg/
ml)^neomycin (10 mg/ml) mixture (Sigma), 25.0 mg/l
heparin, 2 mM glutamate, and 12.5 mg/l ascorbate
before the initiation of hypoxia or control incubation
in L-arginine-free medium. Cells were reoxygenated
with media composed of di¡erent amounts of L-argi-
nine (0^2000 WM) in the presence of DBBF-Hb
(60 WM in heme).
2.5. Endothelial cell model of glutathione depletion
Endothelial cells grown in monolayers were de-
pleted of glutathione (GSH) by treatment with
1 mM of buthionine sulfoximine (BSO), an inhibitor
of Q-glutamyl-cysteine synthetase, for 15 h. After
BSO treatment, cellular GSH was estimated by mea-
suring total soluble reduced thiols by the 5,5-dithio-
bis(2-nitrobenzoic acid) (DTNB) assay. Although
this assay is not speci¢c for GSH, it has previously
been reported that GSH is the primary thiol mea-
sured in endothelial cells with this assay [20].
Brie£y, cells subcultured in 6-well plates were
washed with Hanks’ balanced salt solution, and
0.6 ml of 2% (w/v) 5-sulfosalicylic was added. After
centrifuging the samples for 5 min at 10 000Ug, ali-
quots (500 Wl) were mixed with 500 Wl of freshly
prepared DTNB solution (0.3 M sodium phosphate,
10 mM EDTA, and 0.2 mM DTNB). After 5 min,
the absorbance was measured at 412 nm. Calcula-
tions were based on the extinction coe⁄cient of
13.4 mM31 cm31 derived from glutathione stan-
dards.
2.6. Analysis of lipid peroxidation
Hypoxic cells (2U105 cells) were resuspended in
their original oxygenated medium for 60 min before
the ¢nal removal of the overlying medium and im-
mediate chloroform/methanol extraction [19]. Lipid
extracts were analyzed at 234 nm. The concentration
of conjugated dienes was estimated using the molar
extinction coe⁄cient of 2.54U104 [21].
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2.7. Measurement of mitochondrial function
Mitochondrial function was determined by mea-
suring the conversion of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) to formazan
[22]. Cells were grown to con£uence in 24-well plates.
At a given treatment time interval, cells were washed
once and incubated in 1 ml of culture medium con-
taining 0.1 mg/ml MTT for 2 h. Cells were then
washed once and solubilized in 0.5 ml of dimethyl
sulfoxide (DMSO). The amount of MTT reduced to
formazan in cells was determined by measuring the
absorbance at 570 nm using background correction
at 650 nm.
2.8. Detection of hemoprotein oxidation in endothelial
cell culture
Oxidation of hemoglobin/myoglobin was moni-
tored spectrophotometrically and multicomponent
analysis was used to calculate the total heme and
the percent of the oxy, met and ferryl form of the
proteins [23]. The ferryl heme was also detected by its
reaction with sodium sul¢de in cell culture medium.
Sodium sul¢de (Na2S) (2 mM) was added to the
media at speci¢c time intervals and incubated for
30 min before spectrophotometric detection of sulf-
heme at 620 nm using a Perkin Elmer Lambda 18
dual beam spectrophotometer (Norwalk, CT). The
concentration of sulfheme was estimated using the
extinction coe⁄cient of sulfheme (O620ÿ604 nm = 10.5
mM31 cm31) [24].
2.9. Statistical analysis
Data are expressed as means þ S.E.M. Data anal-
ysis was performed using analysis of variance and
Student’s paired t-test ; P90.05 was considered sig-
ni¢cant. All statistical calculations were performed
with JMP 3.2.1 (SAS Institute Inc., Cary, NC).
3. Results
We and others previously established dose^re-
sponse curves for hypoxia, and measured other pa-
rameters to con¢rm the presence of anaerobic metab-
olism in this hypoxia/reoxygenation model [9,19].
Lactate levels in media of cells that were subjected
to 0^6 h of hypoxia increased from 0.05 þ 0.05 to
0.40 þ 0.08 Wmol/106 cells. Hydrogen peroxide accu-
mulated in cell media up to 10 nmol/106 cells over 5 h
of hypoxia [9].
Time-dependent changes in the oxidation states of
hemoglobin or myoglobin were monitored in the
presence of normal or hypoxic cells. In these experi-
ments, normal or hypoxic cells were incubated with
60 WM of DBBF-Hb or Mb, and spectra were re-
corded in the visible and Soret regions. Fig. 1 shows
typical oxidation pro¢les of DBBF-Hb in cell culture
subjected to normoxic or hypoxic conditions. The
oxidation of hemoglobin occurred during reoxygena-
tion, as witnessed by the loss of absorption at the 577
and 541 nm bands typical of oxyhemoglobin, yield-
ing a ¢nal spectrum at 6 h with a characteristic ab-
sorption at 630 nm indicative of methemoglobin
(Fe3). With hypoxic cells, the disappearance of the
oxyhemoglobin (Fe2) form is accompanied by a
burst in the ferrylhemoglobin in the ¢rst hour, as
evidenced by the appearance of a new peak at 545
nm and a £attened region between 600 and 700 nm.
Mb oxidation followed the same pattern as that ob-
served with DBBF-Hb. Multicomponent analysis of
these spectra was used to monitor the presence of the
ferryl species in DBBF-Hb and Mb samples collected
during reoxygenation (Fig. 1, inset). There was a
V50% increase in the ferryl species of both DBBF-
Hb and Mb following a 1-h reoxygenation period
with hypoxic cells. At 16 h, the ferryl form of Mb
was still detectable whereas ferryl DBBF-Hb had dis-
appeared which re£ects the di¡erences in the half-life
of these ferryl intermediates (ferryl DBBF-Hb V1/2
h and ferryl Mb V8 h) [10,25]. In normal cells (non-
hypoxic), the ferryl form of DBBF-Hb or Mb was
barely detectable at 1 or 16 h (data not shown). The
presence of ferryl DBBF-Hb and Mb in this system
was also con¢rmed via its derivatization to sulfhemo-
globin by Na2S. Sulfhemoglobin was detectable with
hypoxic cells at 1 h of reoxygenation, but was not
observed after 20 h (data not shown).
Conjugated diene formation, an index of lipid per-
oxidative damage, was assessed following reoxygena-
tion of hypoxic cells with DBBF-Hb and Mb (Fig.
2). Normal (non-hypoxic) cells incubated for 1 h
with DBBF-Hb and Mb underwent a 10 and 25%
increase in peroxidation, respectively. This increase
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in lipid peroxidation with non-hypoxic cells may
have resulted from iron- or heme-mediated processes
associated with the slow autoxidation that occurs
under normoxic conditions at this temperature [7].
Compared to non-hypoxic control cells, hypoxic cells
reoxygenated with medium alone produced 30% in-
crease in peroxidation compared to V70% for both
DBBF-Hb and Mb. These results suggest the oxida-
tive stress produced during reoxygenation alone is
su⁄cient to trigger some oxidative damage, which
may be aggravated by the presence of hypoxia and
hemoproteins.
In order to study the potential contribution of the
NO pathway to the pro-oxidant e¡ect of hemopro-
tein, normal and hypoxic cells in L-arginine-free me-
dium were exposed to 60 WM of hemoprotein, and
the concentration of L-arginine in the medium was
varied from 0 to 2000 WM. Fig. 3 shows typically
that L-arginine (0^900 WM) caused a dose-dependent
decrease in ferryl DBBF-Hb formation in both nor-
mal and hypoxic cells. Increasing the L-arginine con-
centration to 2 mM, however, reversed this trend and
slightly increased the amount of ferryl hemoglobin
formation in both normal and hypoxic cells.
Fig. 4A shows GSH levels, estimated by measuring
total soluble reduced thiols, in endothelial cells incu-
bated with DBBF-Hb and Mb with or without bolus
addition of H2O2. Under these conditions, H2O2,
DBBF-Hb, or Mb alone had no e¡ect on GSH lev-
Fig. 2. E¡ect of DBBF-Hb and myoglobin on lipid peroxida-
tion following hypoxia/reoxygenation. After a 4-h period of hy-
poxia, cells were resuspended in their original oxygenated me-
dium alone or with 60 WM DBBF-Hb or Mb for 1 h. Cell
lipids were extracted and analyzed at 234 nm for conjugated di-
enes, an indicator of lipid peroxidation. Values represent the
means þ S.E.M. from three separate experiments. *Hemoprotein
vs. medium P6 0.05.
Fig. 1. Changes in the absorbance spectra of DBBF-Hb (60
WM) following the addition to (A) normal and (B) hypoxic en-
dothelial cells. Samples were taken at various times following
reoxygenation, and absorbance spectra were recorded using a
Perkin-Elmer spectrophotometer. The characteristic spectrum of
ferrylhemoglobin (Fe4) was detectable at 1 h of reoxygenation
of hypoxic cells. At 6 h, methemoglobin (Fe3) formation had
occurred as indicated by the increase at 630 nm. These repre-
sentative spectra were collected from a single experiment. (Inset)
Ferryl intermediate determination using multicomponent analy-
sis of absorbance spectra collected after 1 and 16 h of reoxyge-
nation of hypoxic cells with 60 WM of DBBF-Hb or Mb. To
compare DBBF-Hb and Mb, the values are reported as the in-
crease in ferryl relative to their respective ferryl concentration
at T = 0.
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els. However, the combination of H2O2 and DBBF-
Hb or Mb signi¢cantly decreased GSH levels. Since
GSH may be consumed or decreased, possibly as
part of a protective mechanism, hemoprotein-in-
duced oxidative stress may be particularly damaging
when antioxidant status is lowered as is the case in
many disease states [26,27]. To model the lowered
antioxidant status, we targeted the production of
GSH, the most abundant non-protein thiol in these
cells, with BSO, a speci¢c enzyme inhibitor of the
GSH production pathway. Pretreatment of endothe-
lial cells with 1 mM of BSO for 15 h decreased total
soluble reduced thiols, mainly representing cellular
GSH, by V75% as can be seen in Fig. 4B.
Fig. 5A shows the e¡ects of H2O2 (500 WM) and
DBBF-Hb or Mb (50 WM) on cell viability, based on
the conversion of MTT to formazan by active mito-
chondria from living cells, in the GSH depletion
model. With normal cells, DBBF-Hb/H2O2 or Mb/
H2O2 did not decrease viability within the 4-h peri-
od. Although this MTT assay suggests low toxicity
towards mitochondria of normal cells, other param-
eters of cellular damage, such as lactate dehydrogen-
ase release, have been shown to increase under sim-
ilar conditions [8]. With GSH-depleted cells, both
DBBF-Hb/H2O2 and Mb/H2O2 decreased viability
by 29 þ 5% and 44 þ 6% respectively compared to
BSO-treated control cells. As shown in Fig. 5B, a
possible explanation for the greater toxicity observed
with Mb compared to DBBF-Hb may be the persis-
tence of the ferryl intermediate of myoglobin. In-
deed, sulfhemoglobin measured in medium samples
Fig. 4. (A) Determination of cellular GSH, estimated by mea-
suring total soluble reduced thiols, following a 2-h incubation
with medium alone, DBBF-Hb (50 WM) or Mb (50 WM) with
and without 500 WM H2O2. Results were recorded as nmol of
total reduced thiols/106 cells and reported as percent of control
(medium, no H2O2) þ S.E.M. for 3^4 experiments done in dupli-
cate or triplicate. (B) Total reduced thiols following a 15-h
treatment with 1 mM BSO, an inhibitor of Q-glutamyl-cysteine
synthetase. Values are reported as nmol of total reduced thiols/
106 cells þ S.E.M. for three experiments done in triplicate.
Fig. 3. E¡ect of L-arginine on the ferryl formation following
hypoxia/reoxygenation. Ferryl intermediate was measured using
the sulfhemoglobin assay (see Section 2). Hypoxic (3 h) or nor-
mal cells were resuspended in their original oxygenated me-
dium, plus 60 WM DBBF-Hb and the indicated concentrations
of L-arginine. Na2S (2 mM) was added after 1 h of exposure of
normal or hypoxic/reoxygenated cells to hemoglobin. Sulfhemo-
globin concentration (WM) as the mean þ S.E.M. of the indi-
cated number of experiments (ANOVA). Means that are signi¢-
cantly di¡erent from control cells are marked with * and means
that are signi¢cantly di¡erent from ischemic minus hemoglobin
are marked with ** (P6 0.05).
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collected at the end of treatment from both normal
and GSH-depleted cells contained V7 WM ferryl Mb
compared to little or no ferryl DBBF-Hb. Prior to
addition of H2O2 (T = 0), the initial levels of sulfhe-
moglobin in DBBF-Hb and Mb were 2.9 þ 0.15 and
2.61 þ 0.59 WM, respectively. In separate experiments,
we exposed DBBF-Hb and Mb to 5 molar excess
H2O2, and changes in the visible spectra were re-
corded. Both proteins underwent rapid oxidation
and ferryl protein formation as evidenced by the ap-
pearance of a typical ferryl spectral intermediate. As
time proceeds, however, there was a rapid reversion
(auto-reduction) in the ferryl intermediate of DBBF-
Hb to its ferric form within 1^2 h consistent with its
well-known pseudoperoxidase activity [10]. The ferryl
form of Mb, however, persisted longer in solutions
consistent with its longer half-life of 8 h (data not
shown) [25].
4. Discussion
The introduction of cell-free hemoglobin into the
circulation that occurs under a number of conditions,
e.g. extracorporeal blood £ow during coronary ar-
tery bypass surgery, intracranial hemorrhage, burn
injuries, hemodialysis and trauma [28^32] or when
using hemoglobin blood substitutes, increases the ox-
idative burden on the vasculature due to its exposure
to large amounts of heme. Both cell-free hemoglobin
and myoglobin released from cells as a result of
crush or compression injury [3,4] can be in close
proximity to vascular endothelium at the site of in-
jury, while cells in interstitial spaces can become
exposed due to extravasation of these reactive mole-
cules. Both heme-containing proteins can exacerbate
tissue necrosis and can potentially cause cellular
damage and death away from the primary site of
injury. Although both hemoglobin and myoglobin
can produce tissue-damaging free radical intermedi-
ates upon oxidation, the underlying mechanism of
toxicity has been di⁄cult to assess.
Endothelial cells grown on microcarrier beads can
be exposed to varying amounts of culture medium
that provides oxygen and nutrients and also serves
to eliminate metabolic waste. A particular advantage
of this model is that a number of conditions resem-
bling ischemia can be mimicked in a small volume
test tube. In addition, reoxygenation media can then
be applied, allowing the measurement of redox
events, at any time following hypoxia in hemopro-
tein-containing medium.
The ferryl form of both hemoglobin and myoglo-
bin is formed via the reaction of the oxy or met
forms of these proteins with molar excess of hydro-
gen peroxide. We recently described a mechanism
composed of three steps to account for the oxidation
of hemoproteins with peroxide: (1) initial oxidation
of oxy to ferryl heme, (2) autoreduction of ferryl
intermediate to ferric heme, and (3) reaction of ferric
Fig. 5. (A) Cell viability assessed by mitochondrial reduction of
MTT. Normal cells and cells pretreated with BSO for 15 h
were incubated with medium alone (control), 50 WM DBBF-Hb
or 50 WM Mb (horse skeletal muscle) with 500 WM H2O2. After
4 h, the reduction of MTT to formazan was analyzed. Values
are reported as the means of absorbance readings at 570
nm þ S.E.M. of quadruplicate determinations for three separate
experiments. *BSO-Mb/H2O2 vs. BSO-control P6 0.05; **BSO-
Mb/H2O2 vs. BSO-DBBF/H2O2 P6 0.05. (B) The presence of
ferryl intermediates, measured as sulfhemoglobin, in 4-h sam-
ples collected from the experimental treatments in (A).
BBAMCR 14584 19-1-00
F. D’Agnillo et al. / Biochimica et Biophysica Acta 1495 (2000) 150^159156
heme with additional peroxide to regenerate the fer-
ryl heme, creating a ferric/ferryl catalytic cycle [10,
14]. The detection of ferryl heme in our hypoxia/re-
oxygenation model is an example of a biological
oxidation of hemoglobin that mimics the more famil-
iar reactions of hemoglobin seen in simpler mixtures.
This model system allows us to administer at various
times during hypoxia or reoxygenation any agents
aimed at reducing hemoprotein and reperfusion-
mediated injury. Interestingly, an intervention that
exhibited a marked e¡ect on the oxidation of hemo-
globin in this system was an optimum concentration
of L-arginine, the substrate of nitric oxide synthases.
One possible mechanism that may explain the bipha-
sic nature of this response is the direct reduction of
ferryl hemoglobin by NO, a product of the L-arginine
pathway [16]. Endothelial NO synthase has recently
been shown to exhibit a biphasic pattern of nitrite
production in porcine pulmonary artery endothelial
cells, similar to the pattern of hemoglobin oxidation
in our model, with a maximum between 100 and
500 WM exogenous L-arginine [33]. At the higher L-
arginine concentrations, the uninhibited production
of ferryl hemoglobin may indicate a reduced level
of NO due to substrate inhibition of NO synthase.
Peroxynitrite (ONOO3), a reaction product of NO
with Oc32 , has been shown to have anti-ferryl activity
[34], and may also potentially suppress or enhance
ferryl hemoglobin levels in media containing varying
concentrations of L-arginine. Interestingly, it was re-
cently shown that L-arginine supplementation prior
to hypoxia protected against reoxygenation-induced
injury in isolated perfused rat hearts, supporting the
concept that NO plays an antioxidant role [35].
Although no in vivo evidence suggests that the
cytotoxicity is directly associated with the ferryl
iron, it is instructive to draw comparisons with a
disease known to be caused by the release of hemo-
proteins into the vasculature. In rhabdomyolysis, se-
vere muscle breakdown leads to myoglobin release
into the bloodstream, accumulating in the kidney
and causing kidney failure. A causative role for the
redox cycling between ferric/ferryl forms of myoglo-
bin in initiating free radical-mediated lipid peroxida-
tion and ultimately tissue damage was con¢rmed [6].
Interestingly, alkalization of urine was found to in-
hibit the redox cycling of myoglobin in these ani-
mals. This o¡ers an interesting insight into the
pathogenesis and potentially is a useful strategy in
the treatment of rhabdomyolysis-induced renal fail-
ure. Recent mechanistic studies on the role of myo-
globin oxidation reactions in ischemia-reperfusion in-
jury con¢rm the degree to which the decrease in pH,
PO2 and the presence of adventitious metals can in-
deed signi¢cantly aggravate the oxidative stress asso-
ciated with ischemia/reperfusion [36].
We previously demonstrated that exogenous H2O2
and ONOO3 produced a concentration-dependent
increase in phosphatidylserine externalization on
the plasma membranes of BAECs, an event that
characterizes the early stages of apoptosis [37]. This
e¡ect was inhibited by pre-treating the cells with in-
hibitors of caspases, the executioner enzymes of
apoptosis. In the presence of hemoproteins, H2O2
and ONOO3 induced primarily necrosis as opposed
to apoptosis, suggesting a role for heme-mediated
cytotoxicity. In this study, we were able to extend
this observation and propose a role for ferryl heme
in mediating cell toxicity. Interestingly, horse skeletal
myoglobin with longer and more persistent ferryl
iron (V8 h) was more cytotoxic than ferryl DBBF-
Hb, possibly since the latter was auto-reduced to a
less toxic ferric heme. However, it should be noted
that the reaction of DBBF-Hb with H2O2 does pro-
duce a more persistent ferryl intermediate in solution
compared to HbA0 re£ecting the slower redox cy-
cling of DBBF-Hb [10,18].
GSH forms the largest pool of non-protein thiols
in the body, being the major antioxidant in the cell
[38]. The rate and the capacity of GSH-based pro-
tective processes are dependent on the intracellular
concentration of this thiol-containing tripeptide. In
the hypoxia/reoxygenation model, we previously
showed that endothelial GSH levels were unchanged
in the presence of hemoproteins and H2O2, produced
during the early stages of reoxygenation following
hypoxia, possibly due to the low levels of H2O2 [9].
In this study, we showed that the combination of
H2O2 and hemoproteins signi¢cantly decreased
GSH suggesting a possible protective response
against hemoprotein oxidative stress. In red blood
cells, GSH maintains redox balance and exists in
1:1 stoichiometric quantities with hemoglobin. Re-
cently, it was shown that GSH-depleted lung ¢bro-
blasts were more sensitive to hydrogen peroxide-in-
duced apoptosis and necrosis [39]. Similarly, it has
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been shown that GSH-depleted spinal cord neurons
were more susceptible to hemoglobin-induced toxic-
ity [40]. Endogenous GSH was also shown to play a
role in protecting cerebral endothelial cells from ox-
idative injury following mechanical trauma [41]. In-
deed, many in vivo and in vitro studies have shown
that depletion of intracellular GSH occurs under
conditions such as ischemia/reperfusion, sepsis, and
exposure to lipopolysaccharide, with oxidative stress
being the purported mechanism [42,43]. Lowering
endogenous GSH with BSO, to mimic certain disease
state conditions, may be a useful approach to study
the mechanisms underlying hemoprotein oxidative
stress. Cell-free hemoproteins may present a low
risk to healthy individuals with normal redox status,
however, patients with a compromised vasculature
and poor antioxidant status, i.e. diabetes, hyperten-
sion, myocardial infarction and acute ischemic stroke
[26,27], may be at greater risk, as recent clinical trial
failures with diaspirin cross-linked hemoglobin have
clearly demonstrated [44]. Since hemoglobin and my-
oglobin can interact with endothelial cells when re-
leased into the vascular system, it is important to
consider the redox status of these cells under a vari-
ety of pathophysiological states. Redox status is a
general measure of the ability to withstand an oxi-
dative insult or the general health of the organism,
therefore, this endothelial oxidative stress model sys-
tem may be useful in studying the e¡ects of varying
speci¢c parameters on the ischemia/reperfusion-in-
duced injury.
In summary, we have developed a cell culture sys-
tem that is both easy to employ and amenable to
manipulation to investigate the cellular processes
underlying the pathogenesis of ischemia/reperfusion.
We were able to monitor the transition in the redox
status of hemoproteins and identify the causative
agent, the ferryl heme in mediating cellular toxicity,
under physiologically relevant oxidative stress condi-
tions.
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